Studies on the antifertility effect and metabolism of a new, postcoital oral contraceptive, 2-methyl-3-ethyl-4-phenyl-delta-4-cyclohexene carboxylic acid, sodium salt (ORF-4463).
D000818:Animals; D003270:Contraceptive Agents / Q000037:antagonists & inhibitors; D003276:Contraceptives, Oral / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology* / Q000652:urine; D003307:Copulation; D003509:Cyclohexanecarboxylic Acids / Q000378:metabolism* / Q000494:pharmacology*; D005187:Fallopian Tubes / Q000032:analysis / Q000187:drug effects; D005260:Female; D005306:Fertilization / Q000187:drug effects*; D000882:Haplorhini; D010063:Ovum / Q000187:drug effects; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D011335:Proadifen / Q000494:pharmacology; D011339:Probenecid / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013053:Spectrophotometry; D014316:Tritium
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D003509:Cyclohexanecarboxylic Acids; D014316:Tritium; D011335:Proadifen; D011339:Probenecid